Currently, only about 10% of cancer patients in sub-Sahara Africa receive chemotherapy treatment. More than a half million people are diagnosed with cancer in the region annually, while nearly the same number die from it each year, too. Without intervention, that toll is expected to double by 2030, partly because as people are otherwise living longer, thanks to better malaria and HIV treatments and prevention. But chemotherapy and related drugs are both expensive and tricky to use because there are so many types and stages of the disease.
